In mid-October, Guo Guangchang, founder of Fosun, flew to Mumbai in his private plane to attend the dinner celebrating the Chinese conglomerate’s purchase of Indian pharma company Gland. For many weeks, approval for the transaction had been held up — hostage to the border dispute between India and China in Doklam. The situation was finally resolved not because Delhi signed off but because Gland’s founder, PVN Raju, agreed to sell a smaller portion of his holdings, bringing the transfer below the 74 per cent threshold that triggered the need to secure the government’s blessing. Over mao-tai, (which the Fosun people claimed cost $1,000 a bottle), Mr Guo, clad in jeans and a T-shirt, said he hoped to do many more deals in India, according to several attendees. Fosun has already joined the many Chinese companies backing tech start-ups in the country.
10月中旬，復星集團(Fosun)創始人郭廣昌乘坐自己的私人飛機前往孟買出席這家中國綜合企業收購印度制藥商Gland的慶祝晚宴。受制于印中兩國在多蘭（Doklam，中國稱洞朗——譯者注）的邊境爭端，該交易在好幾周期間遲遲未能獲得批準。這一局面最終得以解決，并不是因為新德里方面放行，而是因為Gland的創始人PVN Raju同意出售較少股份，使得股權轉讓份額低于74%的門檻——超過這一門檻的交易必須獲得印度政府批準。據一些參加晚宴的人介紹，身著牛仔褲和T恤衫的郭廣昌舉著裝著茅臺（復星員工稱一瓶茅臺的價格為1000美元）的酒杯說，他希望在印度做成更多交易。復星已經加入了支持印度科技初創企業的中國企業大軍。